Vascular response to vasodilator treatment in microalbuminuric diabetic kidney disease.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  World Journal of Nephrology

• Publication date

  2013-11-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.5527/wjn.v2.i4.125PMID 24255895PMCID PMC3832868
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vascular Homeostasis and Angiogenesis Determine Therapeutic Effectiveness in Type 2 Diabetes

  2011cited by this paper
• Enhanced Peritubular Capillary Flow and Renal Function Can Be Accomplished in Normoalbuminuric Type 2 Diabetic Nephropathy

  2011cited by this paper
• ACEI and ARB combination therapy in patients with macroalbuminuric diabetic nephropathy and low socioeconomic level: a double-blind randomized clinical trial.

  2011cited by this paper
• Vascular homeostasis in early (normo-albuminuric) type 2 diabetic nephropathy

  2010cited by this paper
• Therapeutic strategy towards renal restoration in chronic kidney disease

  2010cited by this paper
• Altered Vascular Homeostasis in Type 2 Diabetic Nephropathy

  2009cited by this paper
• Renal vascular endothelial function in hypertensive patients with type 2 diabetes mellitus.

  2009cited by this paper
• New Horizons in Diabetes Therapy: The Angiogenesis Paradox in Diabetes: Description of the Problem and Presentation of a Unifying Hypothesis

  2007cited by this paper
• A Biomarker for Detecting Early Tubulointerstitial Disease and Ischemia in Glomerulonephropathy

  2007cited by this paper
• Increasing telmisartan vs amlodipine dose in patients with hypertension, type 2 diabetes and microalbuminuria

  2007cited by this paper
• Uncoupling of vascular endothelial growth factor with nitric oxide as a mechanism for diabetic vasculopathy.

  2006cited by this paper
• Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man.

  2006cited by this paper
• Preventing microalbuminuria in type 2 diabetes.

  2005cited by this paper
• Tubular dysfunction and hemodynamic alteration in normoalbuminuric type 2 diabetes

  2005cited by this paper
• Antihypertensive agents for primary prevention of diabetic nephropathy.

  2005cited by this paper
• Early detection of endothelial dysfunction and early therapeutic correction effectively restore renal function in type 2 diabetic nephropathy.

  2005cited by this paper
• Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).

  2004cited by this paper
• Preventing microalbuminuria in type 2 diabetes.

  2004cited by this paper
• Optimizing therapy in the diabetic patient with renal disease: antihypertensive treatment.

  2004cited by this paper
• Quantitave and qualitative changes in vascular endothelial growth factor gene expression in glomeruli of patients with type 2 diabetes.

  2004cited by this paper
• Endothelial Cell Dysfunction Leading to Diabetic Nephropathy: Focus on Nitric Oxide

  2001cited by this paper
• Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

  2000cited by this paper
• Tubular function and tubulointerstitial disease.

  1999cited by this paper

• Natural health wellness: an effective prevention of DKD

  2019cites this paper
• Biomarker for early renal microvascular and diabetic kidney diseases

  2017influential citation
• A Self-Sufficiency Philosophy for Non-Communicable Disease Control

  2017cites this paper
• Early stage of vascular disease and diabetic kidney disease: an under-recognized entity

  2015cites this paper